These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 24258576)

  • 1. Juvenile xanthogranuloma and nevus anemicus in the diagnosis of neurofibromatosis type 1.
    Ferrari F; Masurel A; Olivier-Faivre L; Vabres P
    JAMA Dermatol; 2014 Jan; 150(1):42-6. PubMed ID: 24258576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nevus anemicus in neurofibromatosis type 1: a potential new diagnostic criterion.
    Marque M; Roubertie A; Jaussent A; Carneiro M; Meunier L; Guillot B; Pinson L; Pinson S; Bessis D
    J Am Acad Dermatol; 2013 Nov; 69(5):768-775. PubMed ID: 23972508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nevus Anemicus As an Additional Diagnostic Marker of Neurofibromatosis Type 1 in Childhood.
    Vaassen P; Rosenbaum T
    Neuropediatrics; 2016 Jun; 47(3):190-3. PubMed ID: 27019377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nevus anemicus: a distinctive cutaneous finding in neurofibromatosis type 1.
    Hernández-Martín A; García-Martínez FJ; Duat A; López-Martín I; Noguera-Morel L; Torrelo A
    Pediatr Dermatol; 2015; 32(3):342-7. PubMed ID: 25690591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous and Systemic Findings in Mosaic Neurofibromatosis Type 1.
    Vázquez-Osorio I; Duat-Rodríguez A; García-Martínez FJ; Torrelo A; Noguera-Morel L; Hernández-Martín A
    Pediatr Dermatol; 2017 May; 34(3):271-276. PubMed ID: 28318056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nevus anemicus associated with neurofibromatosis type 1 in a neonate: a case report.
    Cerini C; Pogliani L; Mameli C; Zuccotti GV
    G Ital Dermatol Venereol; 2015 Dec; 150(6):745-7. PubMed ID: 26513044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofibromatosis type 1 diagnosed in a child based on multiple juvenile xanthogranulomas and juvenile myelomonocytic leukemia.
    Jans SR; Schomerus E; Bygum A
    Pediatr Dermatol; 2015; 32(1):e29-32. PubMed ID: 25516272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous Manifestations not Considered Diagnostic Criteria for Neurofibromatosis Type 1. A Case-Control Study.
    García-Martínez FJ; Duat-Rodríguez A; Andrés Esteban E; Torrelo A; Noguera Morel L; Hernández-Martín A
    Actas Dermosifiliogr; 2022; 113(10):T923-T929. PubMed ID: 36162491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous Manifestations not Considered Diagnostic Criteria for Neurofibromatosis Type 1. A Case-Control Study.
    García-Martínez FJ; Duat-Rodríguez A; Andrés Esteban E; Torrelo A; Noguera Morel L; Hernández-Martín A
    Actas Dermosifiliogr; 2022; 113(10):923-929. PubMed ID: 35636506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Juvenile Myelomonocytic Leukemia, Juvenile Xanthogranulomas and Neurofibromatosis Type 1: Case Report and Review of the Literature.
    Paulus S; Koronowska S; Fölster-Holst R
    Pediatr Dermatol; 2017 Mar; 34(2):114-118. PubMed ID: 28111791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofibromatosis Type 1: Diagnostic Timelines in Children.
    García-Martínez FJ; Hernández-Martín A
    Actas Dermosifiliogr; 2023 Mar; 114(3):187-193. PubMed ID: 36370836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Juvenile xanthogranuloma associated with neurofibromatosis 1: 14 patients without evidence of hematologic malignancies.
    Cambiaghi S; Restano L; Caputo R
    Pediatr Dermatol; 2004; 21(2):97-101. PubMed ID: 15078345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What's new with common genetic skin disorders?
    Hand JL
    Curr Opin Pediatr; 2015 Aug; 27(4):460-5. PubMed ID: 26164153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anemic nevus in neurofibromatosis type 1.
    Tadini G; Brena M; Pezzani L; Gelmetti C; Santagada F; Boldrini MP
    Dermatology; 2013; 226(2):115-8. PubMed ID: 23713063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Juvenile xanthogranuloma, neurofibromatosis, and juvenile chronic myelogenous leukemia. World statistical analysis.
    Zvulunov A; Barak Y; Metzker A
    Arch Dermatol; 1995 Aug; 131(8):904-8. PubMed ID: 7632061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vivo Detection of Choroidal Abnormalities Related to NF1: Feasibility and Comparison With Standard NIH Diagnostic Criteria in Pediatric Patients.
    Parrozzani R; Clementi M; Frizziero L; Miglionico G; Perrini P; Cavarzeran F; Kotsafti O; Comacchio F; Trevisson E; Convento E; Fusetti S; Midena E
    Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):6036-42. PubMed ID: 26393470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of café au lait macules at initial consultation in the diagnosis of neurofibromatosis type 1.
    Nunley KS; Gao F; Albers AC; Bayliss SJ; Gutmann DH
    Arch Dermatol; 2009 Aug; 145(8):883-7. PubMed ID: 19687418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between neurofibromatosis type 1, juvenile xanthogranuloma, and malignancy: A retrospective case-control study.
    Liy-Wong C; Mohammed J; Carleton A; Pope E; Parkin P; Lara-Corrales I
    J Am Acad Dermatol; 2017 Jun; 76(6):1084-1087. PubMed ID: 28189268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Juvenile xanthogranuloma in a child with previously unsuspected neurofibromatosis type 1 and juvenile myelomonocytic leukemia.
    Raygada M; Arthur DC; Wayne AS; Rennert OM; Toretsky JA; Stratakis CA
    Pediatr Blood Cancer; 2010 Jan; 54(1):173-5. PubMed ID: 19785027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated head circumference-to-height ratio is an early and frequent feature in children with neurofibromatosis type 1.
    Karvonen M; Saari A; Hannila ML; Lönnqvist T; Dunkel L; Sankilampi U
    Horm Res Paediatr; 2013; 79(2):97-102. PubMed ID: 23466600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.